{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:14:04Z","timestamp":1770434044647,"version":"3.49.0"},"reference-count":11,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T00:00:00Z","timestamp":1233187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Forensic Sciences"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Gamma\u2010hydroxybutyrate (GHB) is best known as a recreational depressant drug, whose use has also been implicated in drug facilitated sexual assault cases. It is also available as a therapeutic agent (Xyrem<jats:sup>\u00ae<\/jats:sup>) used for the treatment of daytime sleepiness or cataplexy associated with narcolepsy. This is a report of a case of a 53\u2010year\u2010old woman undergoing treatment with Xyrem<jats:sup>\u00ae<\/jats:sup> for narcolepsy. The decedent was also prescribed tramadol, gabapentin, cetirizine, modafinil, carisoprodol, and Xyrem<jats:sup>\u00ae<\/jats:sup>. Toxicological analysis of the blood revealed GHB 165.6\u2003mg\/L, and 90.7\u2003mg\/L in the urine. Blood GHB concentrations in the range 156\u2013260\u2003mg\/L have been reported to induce moderately sound sleep. The combined use of central nervous system depressant drugs, together with her problematic sleep apnea, and snoring (both contraindications for GHB use) were determined to have caused this subject\u2019s death. The manner of death was determined to be accidental.<\/jats:p>","DOI":"10.1111\/j.1556-4029.2008.00965.x","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T17:13:35Z","timestamp":1233249215000},"page":"495-496","source":"Crossref","is-referenced-by-count":39,"title":["A Multi\u2010Drug Intoxication Fatality Involving Xyrem<sup>\u00ae<\/sup> (GHB)"],"prefix":"10.1111","volume":"54","author":[{"given":"Brianne E.","family":"Akins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estuardo","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Matthew Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry K.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1197\/aemj.9.7.730"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.6.421"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.1.1"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721040-00007"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2007.03.008"},{"key":"e_1_2_6_7_2","volume-title":"FDA talk paper: FDA approves Xyrem for cataplexy attacks in patients with narcolepsy","author":"US Food and Drug Administration"},{"key":"e_1_2_6_8_2","first-page":"1688","volume-title":"Xyrem\u00ae physician\u2019s desk reference","year":"2007"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2003.11.002"},{"issue":"1","key":"e_1_2_6_10_2","first-page":"31","article-title":"A 12\u2010month, open\u2010label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy","volume":"26","author":"US. Xyrem\u00ae Multicenter Study Group","year":"2003","journal-title":"Sleep"},{"key":"e_1_2_6_11_2","volume-title":"Xyrem\u00ae (sodium oxybate) oral solution. Product monograph","author":"Jazz Pharmaceuticals, Inc","year":"2005"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-196411000-00007"}],"container-title":["Journal of Forensic Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1556-4029.2008.00965.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1556-4029.2008.00965.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T02:33:29Z","timestamp":1696991609000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1556-4029.2008.00965.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,24]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1556-4029.2008.00965.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1556-4029.2008.00965.x","archive":["Portico"],"relation":{},"ISSN":["0022-1198","1556-4029"],"issn-type":[{"value":"0022-1198","type":"print"},{"value":"1556-4029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,24]]}}}